Care Giant Posts $5.1 Billion Revenue, Investor Grows Stake
A premier eye care company delivers $5.1 billion in revenue, while a prominent investor quietly expands holdings. Her...
Bear markets test retirement portfolios. This piece explains how risk parity may influence drawdowns and resilience, plus practical steps for retirees.
28,208 articlesA premier eye care company delivers $5.1 billion in revenue, while a prominent investor quietly expands holdings. Her...
On July 16, the stock market faced pressure as a major space-tech name announced a $1 billion convertible notes offer...
When cost matters and the hunt for long-term growth begins, Vanguard Small-Cap Value tops the field for many investor...
Inflation reshapes the real estate game. This guide explains why real estate isn’t safe and offers practical steps fo...
Eli Lilly kicked off 2026 with blockbuster sales and higher guidance, reigniting talk of a path to $1800 for Lilly st...
Netflix is trading near its 52-week low as ad-supported growth and cash flow gains reshape investor bets. Analysts di...
A new Federal Reserve briefing warns that hidden tariff costs are shaping consumer prices and policy decisions. Inves...
Ethereum has cooled after a rapid rally, but a dip below $1,000 doesn’t have to derail your strategy. This practical ...
Bitcoin has fallen from recent highs, sparking questions about whether it’s a buying chance or a trap. This guide bre...
The EMB ETF offers a ~6% yield on USD EM debt, but a hidden sovereign default risk can erode income and NAV during ma...
Hedge funds are chasing a single megacap, creating crowded trades. Learn what crowdedness means, how to read the sign...
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...